Table 2:

Prevalence of DVAs in study and control populationsa

TotalDVA+ (%)95% CIZ ScoreP Value
Neoplasm58059 (10.17)7.97–12.903.07.003
Controls58031 (5.34)3.79–7.48
  • Note:—DVA+ indicates the number of subjects in group who had a confirmed DVA.

  • a The neoplasm group had a >10% prevalence of DVAs, compared with just over 5% for the control group. The latter is similar to recently published prevalence data.